US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 3.790
  • +0.480+14.50%
Close Oct 11 16:00 ET
  • 3.800
  • +0.010+0.26%
Post 19:45 ET
310.64MMarket Cap-2129P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
130.31%9.46M
-6.15%-64.74M
-3,245.00%-111.62M
158.97%14.07M
-150.87%-33.5M
-879.13%-31.2M
-73.00%-60.99M
104.35%3.55M
-10.58%-23.86M
369.83%65.85M
Net income from continuing operations
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
Depreciation and amortization
3.41%1.79M
9.04%1.76M
19.79%6.82M
13.29%1.73M
20.93%1.74M
23.91%1.73M
21.70%1.62M
17.46%5.69M
16.20%1.53M
28.62%1.44M
Other non cash items
617.39%8.79M
1,268.47%8.59M
475.63%16.82M
835.93%7.58M
854.26%7.39M
125.18%1.23M
-20.91%628K
-52.56%2.92M
-55.95%810K
-53.18%774K
Change In working capital
514.23%48.37M
31.93%-16.62M
-132.92%-34.38M
-210.30%-21.58M
-95.32%3.74M
-21.92%7.88M
-367.38%-24.41M
692.54%104.41M
524.68%19.57M
8,546.16%79.98M
-Change in receivables
19,425.40%24.35M
273.68%4.78M
-642.15%-28.96M
-571.20%-19.45M
-107.67%-6.63M
99.85%-126K
-458.20%-2.75M
177.46%5.34M
3,429.03%4.13M
2,826.50%86.43M
-Change in prepaid assets
-95.83%306K
67.81%-2.39M
103.08%109K
-10.95%-669K
130.35%868K
2,603.07%7.33M
-3,601.89%-7.42M
10.48%-3.54M
-204.87%-603K
-1,107.04%-2.86M
-Change in payables and accrued expense
-323.37%-6.01M
-20.95%-2.66M
464.21%30.11M
476.77%24.78M
658.59%4.84M
-19.30%2.69M
-54.13%-2.2M
-37.75%5.34M
5.04%4.3M
-131.62%-867K
-Change in other current liabilities
-79.23%-1.55M
-79.57%-1.5M
-341.57%-4.59M
-398.78%-1.46M
-396.25%-1.42M
-280.71%-862K
-285.59%-837K
169.60%1.9M
125.98%490K
189.55%480K
-Change in other working capital
2,788.99%31.27M
-32.51%-14.84M
-132.56%-31.06M
-320.14%-24.78M
289.68%6.08M
-101.26%-1.16M
-114.27%-11.2M
856.15%95.37M
2,259.33%11.25M
-299.75%-3.21M
Cash from discontinued investing activities
Operating cash flow
130.31%9.46M
-6.15%-64.74M
-3,245.00%-111.62M
158.97%14.07M
-150.87%-33.5M
-879.13%-31.2M
-73.00%-60.99M
104.35%3.55M
-10.58%-23.86M
369.83%65.85M
Investing cash flow
Cash flow from continuing investing activities
-221.49%-80.38M
-4.96%64.11M
88.80%-3.92M
37.93%-23.51M
-46.11%-114.02M
38.07%66.16M
104.51%67.45M
64.01%-35.02M
-282.29%-37.88M
-3,380.69%-78.04M
Net PPE purchase and sale
52.87%-756K
52.65%-446K
45.09%-4.32M
57.20%-1.44M
55.56%-328K
27.09%-1.6M
39.34%-942K
48.72%-7.86M
-32.72%-3.37M
85.23%-738K
Net investment purchase and sale
-217.50%-79.62M
-5.62%64.55M
101.44%391K
36.07%-22.07M
-47.08%-113.69M
35.21%67.76M
98.04%68.39M
66.86%-27.17M
-248.11%-34.52M
-2,905.77%-77.3M
Net other investing changes
----
----
----
----
----
----
----
0.00%9K
----
----
Cash from discontinued investing activities
Investing cash flow
-221.49%-80.38M
-4.96%64.11M
88.80%-3.92M
37.93%-23.51M
-46.11%-114.02M
38.07%66.16M
104.51%67.45M
64.01%-35.02M
-282.29%-37.88M
-3,380.69%-78.04M
Financing cash flow
Cash flow from continuing financing activities
-29.91%96.49M
-139.15%-3.43M
184.71%137.55M
-125.57%-3.13M
-119.23%-5.74M
2,409.77%137.66M
1,052.37%8.76M
1,383.81%48.31M
2,315.22%12.22M
2,999.38%29.85M
Net issuance payments of debt
--0
-30.66%-4.08M
-33.33%-12.5M
0.00%-3.13M
0.00%-3.13M
0.00%-3.13M
---3.13M
---9.38M
---3.13M
---3.13M
Net common stock issuance
9,110.59%96.53M
--0
-78.73%11.97M
--0
--0
-87.81%1.05M
--10.92M
803,957.14%56.27M
219,314.29%15.35M
--32.33M
Proceeds from stock option exercised by employees
--0
-27.14%1.03M
25.73%2.37M
--0
37.86%954K
--0
18.97%1.41M
-55.74%1.88M
-99.81%1K
-34.22%692K
Net other financing activities
-100.03%-37K
17.07%-374K
29,412.74%135.72M
--0
-7,038.00%-3.57M
1,074,807.69%139.74M
-5.87%-451K
53.09%-463K
--0
43.82%-50K
Cash from discontinued financing activities
Financing cash flow
-29.91%96.49M
-139.15%-3.43M
184.71%137.55M
-125.57%-3.13M
-119.23%-5.74M
2,409.77%137.66M
1,052.37%8.76M
1,383.81%48.31M
2,315.22%12.22M
2,999.38%29.85M
Net cash flow
Beginning cash position
4.31%66.08M
45.74%70.14M
53.83%48.13M
-15.30%82.71M
195.01%235.97M
112.76%63.34M
53.83%48.13M
-84.89%31.29M
209.23%97.65M
39.68%79.99M
Current changes in cash
-85.19%25.57M
-126.71%-4.07M
30.72%22.01M
74.63%-12.57M
-967.65%-153.26M
243.77%172.62M
1,105.82%15.22M
109.58%16.84M
-16,802.73%-49.53M
168.77%17.66M
End cash Position
-61.16%91.65M
4.31%66.08M
45.74%70.14M
45.74%70.14M
-15.30%82.71M
195.01%235.97M
112.76%63.34M
53.83%48.13M
53.83%48.13M
209.23%97.65M
Free cash flow
126.52%8.7M
-5.25%-65.19M
-2,590.44%-115.93M
146.38%12.63M
-151.95%-33.83M
-508.97%-32.8M
-68.26%-61.93M
95.56%-4.31M
-12.91%-27.23M
321.46%65.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 130.31%9.46M-6.15%-64.74M-3,245.00%-111.62M158.97%14.07M-150.87%-33.5M-879.13%-31.2M-73.00%-60.99M104.35%3.55M-10.58%-23.86M369.83%65.85M
Net income from continuing operations -24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M
Depreciation and amortization 3.41%1.79M9.04%1.76M19.79%6.82M13.29%1.73M20.93%1.74M23.91%1.73M21.70%1.62M17.46%5.69M16.20%1.53M28.62%1.44M
Other non cash items 617.39%8.79M1,268.47%8.59M475.63%16.82M835.93%7.58M854.26%7.39M125.18%1.23M-20.91%628K-52.56%2.92M-55.95%810K-53.18%774K
Change In working capital 514.23%48.37M31.93%-16.62M-132.92%-34.38M-210.30%-21.58M-95.32%3.74M-21.92%7.88M-367.38%-24.41M692.54%104.41M524.68%19.57M8,546.16%79.98M
-Change in receivables 19,425.40%24.35M273.68%4.78M-642.15%-28.96M-571.20%-19.45M-107.67%-6.63M99.85%-126K-458.20%-2.75M177.46%5.34M3,429.03%4.13M2,826.50%86.43M
-Change in prepaid assets -95.83%306K67.81%-2.39M103.08%109K-10.95%-669K130.35%868K2,603.07%7.33M-3,601.89%-7.42M10.48%-3.54M-204.87%-603K-1,107.04%-2.86M
-Change in payables and accrued expense -323.37%-6.01M-20.95%-2.66M464.21%30.11M476.77%24.78M658.59%4.84M-19.30%2.69M-54.13%-2.2M-37.75%5.34M5.04%4.3M-131.62%-867K
-Change in other current liabilities -79.23%-1.55M-79.57%-1.5M-341.57%-4.59M-398.78%-1.46M-396.25%-1.42M-280.71%-862K-285.59%-837K169.60%1.9M125.98%490K189.55%480K
-Change in other working capital 2,788.99%31.27M-32.51%-14.84M-132.56%-31.06M-320.14%-24.78M289.68%6.08M-101.26%-1.16M-114.27%-11.2M856.15%95.37M2,259.33%11.25M-299.75%-3.21M
Cash from discontinued investing activities
Operating cash flow 130.31%9.46M-6.15%-64.74M-3,245.00%-111.62M158.97%14.07M-150.87%-33.5M-879.13%-31.2M-73.00%-60.99M104.35%3.55M-10.58%-23.86M369.83%65.85M
Investing cash flow
Cash flow from continuing investing activities -221.49%-80.38M-4.96%64.11M88.80%-3.92M37.93%-23.51M-46.11%-114.02M38.07%66.16M104.51%67.45M64.01%-35.02M-282.29%-37.88M-3,380.69%-78.04M
Net PPE purchase and sale 52.87%-756K52.65%-446K45.09%-4.32M57.20%-1.44M55.56%-328K27.09%-1.6M39.34%-942K48.72%-7.86M-32.72%-3.37M85.23%-738K
Net investment purchase and sale -217.50%-79.62M-5.62%64.55M101.44%391K36.07%-22.07M-47.08%-113.69M35.21%67.76M98.04%68.39M66.86%-27.17M-248.11%-34.52M-2,905.77%-77.3M
Net other investing changes ----------------------------0.00%9K--------
Cash from discontinued investing activities
Investing cash flow -221.49%-80.38M-4.96%64.11M88.80%-3.92M37.93%-23.51M-46.11%-114.02M38.07%66.16M104.51%67.45M64.01%-35.02M-282.29%-37.88M-3,380.69%-78.04M
Financing cash flow
Cash flow from continuing financing activities -29.91%96.49M-139.15%-3.43M184.71%137.55M-125.57%-3.13M-119.23%-5.74M2,409.77%137.66M1,052.37%8.76M1,383.81%48.31M2,315.22%12.22M2,999.38%29.85M
Net issuance payments of debt --0-30.66%-4.08M-33.33%-12.5M0.00%-3.13M0.00%-3.13M0.00%-3.13M---3.13M---9.38M---3.13M---3.13M
Net common stock issuance 9,110.59%96.53M--0-78.73%11.97M--0--0-87.81%1.05M--10.92M803,957.14%56.27M219,314.29%15.35M--32.33M
Proceeds from stock option exercised by employees --0-27.14%1.03M25.73%2.37M--037.86%954K--018.97%1.41M-55.74%1.88M-99.81%1K-34.22%692K
Net other financing activities -100.03%-37K17.07%-374K29,412.74%135.72M--0-7,038.00%-3.57M1,074,807.69%139.74M-5.87%-451K53.09%-463K--043.82%-50K
Cash from discontinued financing activities
Financing cash flow -29.91%96.49M-139.15%-3.43M184.71%137.55M-125.57%-3.13M-119.23%-5.74M2,409.77%137.66M1,052.37%8.76M1,383.81%48.31M2,315.22%12.22M2,999.38%29.85M
Net cash flow
Beginning cash position 4.31%66.08M45.74%70.14M53.83%48.13M-15.30%82.71M195.01%235.97M112.76%63.34M53.83%48.13M-84.89%31.29M209.23%97.65M39.68%79.99M
Current changes in cash -85.19%25.57M-126.71%-4.07M30.72%22.01M74.63%-12.57M-967.65%-153.26M243.77%172.62M1,105.82%15.22M109.58%16.84M-16,802.73%-49.53M168.77%17.66M
End cash Position -61.16%91.65M4.31%66.08M45.74%70.14M45.74%70.14M-15.30%82.71M195.01%235.97M112.76%63.34M53.83%48.13M53.83%48.13M209.23%97.65M
Free cash flow 126.52%8.7M-5.25%-65.19M-2,590.44%-115.93M146.38%12.63M-151.95%-33.83M-508.97%-32.8M-68.26%-61.93M95.56%-4.31M-12.91%-27.23M321.46%65.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.67%